ScholarWorks@Korea University College of Medicine: Jung, In Kwa

Detailed Information

Jung, In Kwa (정인과)

Guro Hospital (Department of Psychiatry, Guro Hospital)

Research Area

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

schizophrenia:16||polymorphism:9||Depression:4||cognitive function:4||tardive dyskinesia:3||Polymorphism:3||Schizophrenia:3||정신분열병:3||restless legs syndrome:3||negative symptoms:3||risperidone:3||Adherence:3||undifferentiated somatoform disorder:2||polymorphisms:2||계절성:2||KMAS:2||prolactin:2||DRD4:2||antipsychotics:2||brainderived neurotrophic factor:2||Medication Event Monitoring System:2||novelty seeking:2||obesity:2||Stress:2||haloperidol:2||양극성장애:2||Patient Health Questionnaire:2||P300:2||Alzheimer’s disease:2||personality:2||bipolar disorder:2||Emotional support:1||Facial stimuli:1||Females:1||Fluoxetine:1||Functional magnetic resonance imaging:1||Gprotein:1||Gprotein B3 subunit gene:1||General wellbeing:1||Gray matter abnormality:1||Heart rate variability:1||Hippocampus:1||Impairment· Assessment· Neuropsychiatry.:1||Inhalant:1||Insight:1||Internet Addiction:1||Interpersonal Relations:1||KGDS:1||Liver cirrhosis:1||Manganese superoxide dismutase:1||Medication event monitoring system:1||Mental health facility· Length of stay· Contributing factor.:1||Mirtazapine.:1||NMethylDAspartate:1||NMethylDAspartate 수용체:1||Negative Symptoms:1||Neuropsychological function:1||Nonpsychotic depression • Schizophrenia • Neuropsychological test.:1||Olanzapine.:1||Oriental medicine·Western medicine·Seeking behabior ·Personality factor:1||PANSS:1||PHQ15:1||PHQ9:1||PTED:1||Parahippocampus:1||Parenting stress index.:1||Perceived stress scale:1||Pharmacotherapy:1||Postmenopause:1||Pregnancy:1||Premenopause:1||Premenstrual dysphoric disorder:1||Psychiatric characteristics:1||Psychosis.:1||Psychotic depression:1||Reliability:1||SPAQ:1||Serum lipid level·Gemfibrozil·Mood·Neurocognitive function:1||Sleep assessment·Sleep log·Actigraphy.:1||Somatosensory evoked potentials:1||Striatum:1||Subclinical hepatic encephalopathy:1||Substance Abuse:1||Switch:1||Symptom:1||Symptoms:1||TCI:1||Tardive dyskinesia:1||Temperament:1||The elderly·Polypharmacy·Psychiatric drugs:1||Tryptophan hydroxylase 2:1||Validity:1||Valproate:1||Voxel based morphometry:1||adolescent:1||adverse effect:1||amenorrhea:1||angerrelated behavior:1||aripiprazole:1||attention deficit disorder with hyperactivity:1||attitude:1||atypical:1||bromocriptine:1||bupropion:1||butane gas:1||capacity decline theory:1||catecholOmethyltransferase gene:1||clinical trial:1||clozapine:1||combination treatment:1||contributing factor:1||costeffectiveness:1||data collection:1||dehydroepiandrosterone sulfate:1||delirium:1||dependance:1||depot:1||depression:1||dopamine D4 receptor:1||dopamine receptor genes, polymorphism:1||dopamine transporter:1||early increase of the initial dose:1||effectiveness:1||efficacy:1||elder:1||elderly memory:1||estrogen:1||eventrelated potential:1||fMRI:1||fluoxetine:1||free testosterone:1||gene polymorphisms:1||genes:1||hematocrit:1||hemodialysis:1||heterosis:1||hormone replacement therapy:1||hyperprolactinemia:1||informed consent:1||insomnia:1||length of stay:1||leptin gene:1||longacting injectable risperidone:1||longacting injection risperidone:1||longacting injections:1||maintenance:1||major depression:1||major depressive disorder:1||menopause:1||menstruation:1||mental health facility:1||metaanalysis:1||methylphenidate:1||mirtazapine:1||monoamine oxidase a gene:1||monoamine oxidaseA:1||mood disorder:1||neurocognitive function:1||norepinephrine transporter:1||oestrogen:1||olanzapine:1||openlabel:1||overweight:1||paliperidone extended release:1||paroxetine:1||perceived functioning:1||persistant psychotic disorder:1||persistence:1||pilot study:1||premenstrual syndrome:1||psychiatric symptom:1||quality of life:1||remission rate:1||reward dependence:1||risperidone longacting injectable:1||satisfaction:1||seasonality:1||sertraline:1||survey:1||testosterone:1||topiramate:1||treatment response:1||valproic acid:1||waist circumference:1||weight gain:1||weight loss:1||wellbeing:1||women:1||zonisamide:1||간경변증:1||갑상선 기능저하증:1||계절성 정동장애:1||기면증:1||노인·다제요법·정신과적 약물:1||노인우울검사:1||노인우울척도:1||당뇨병:1||두부외상:1||리스페리돈:1||리튬:1||벤라팍신:1||불안:1||수면평가·수면일지·활동기록기.:1||스트레스:1||스트레스 자각척도:1||신뢰도:1||심인성 발기부전:1||아임상적 간성 뇌병증:1||안정성:1||약대:1||약물 순응도·알츠하이머 병·치매:1||약물순응도:1||에스트로겐:1||여학:1||우울:1||음성증상:1||인격:1||인지기능:1||자가면역성 질환:1||전공의 교육:1||전환장애 Meige:1||정신과 문제:1||정신과적 특성:1||정신보건 관련 시설·재원 기간·관련 요인.:1||조증:1||주요우울증:1||주의력결핍 과잉행동장애·심박 변이도·노력 할당·부모의 양육 스트레스 척도.:1||체성감각 유발전위:1||치료효과:1||타당도:1||폐경전기·폐경후기·우울증·Mirtazapine.:1||학제연장:1||한국청소년:1||한의학·양의학·의료추구행동·성격요인:1||07045717:1||항정신병약물치료:1||07045917:1||120064:1||120220:1||4969:1||Abnormal involuntary movements:1||Alexithymia:1||Alzheimer's disease:1||Anger:1||Antenatal depression:1||Antidepressants:1||Anxiety:1||AttentionDeficit/Hyperactivity Disorder:1||Attentiondeficit hyperactivity disorder:1||Attitude:1||Biological marker:1||Bipolar disorder:1||Bone density:1||Bone metabolism:1||CSKGDS:1||Clozapine:1||Cognitive function:1||Coping:1||Dcycloserine:1||DRD2:1||Dementia:1||Depressive disorder:1||Dopamine receptor D2:1||Drug adherence:1||Effort allocation:1||Embitterment:1||

STATISTICS: Total View :12,665,932; Today View :3,206

RSS_1.0 RSS_2.0 ATOM_1.0

73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE